Welcome to LookChem.com Sign In|Join Free
  • or
1,3-dimethoxy-5-(trifluoromethyl)benzene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

158152-56-8

Post Buying Request

158152-56-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

158152-56-8 Usage

Type of compound

Benzene derivative

Substituents

Two methoxy (CH3O) groups and one trifluoromethyl (CF3) group

Applications

Used in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals

Physical state

Colorless liquid

Odor

Sweet

Environmental and human health hazard

Potential hazard

Handling and storage

Must be handled and stored with care due to harmful effects if inhaled, ingested, or brought into contact with the skin

Check Digit Verification of cas no

The CAS Registry Mumber 158152-56-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,1,5 and 2 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 158152-56:
(8*1)+(7*5)+(6*8)+(5*1)+(4*5)+(3*2)+(2*5)+(1*6)=138
138 % 10 = 8
So 158152-56-8 is a valid CAS Registry Number.

158152-56-8Relevant academic research and scientific papers

Catalytic trifluoromethylation of aryl- and vinylboronic acids by 2-cyclopropyl-1-(trifluoromethyl)benzo[ b ]thiophenium triflate

Arimori, Sadayuki,Shibata, Norio

supporting information, p. 1632 - 1635 (2015/04/14)

Catalytic trifluoromethylation of aryl- and vinylboronic acids by 2-cyclopropyl-1-(trifluoromethyl)benzo[b]thiophenium triflate is described. In the presence of a catalytic amount of CuOAc and 2,4,6-collidine in ethyl acetate, the reaction proceeded in good to high yields for various substrates under mild reaction conditions at room temperature.

RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE

-

Paragraph 0140, (2014/09/29)

Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.

A general strategy for the perfluoroalkylation of arenes and arylbromides by using arylboronate esters and [(phen)CuRF]

Litvinas, Nichole D.,Fier, Patrick S.,Hartwig, John F.

, p. 536 - 539 (2012/02/16)

A versatile method for the synthesis of aryl perfluoroalkanes from arenes and aryl bromides is described. Substituted arenes or aryl bromides are converted in situ to an aryl boronate ester that readily undergoes perfluoroalkylation in air with [(phen)CuRF]. A broad range of aryl bromide substrates were perfluoroalkylated in good yield for the first time. [(phen)CuCF3] is now commercially available and has been prepared on 20g scale. Copyright

A ligand-free copper-catalyzed decarboxylative trifluoromethylation of aryliodides with sodium trifluoroacetate using Ag2O as a promoter

Li, Yaming,Chen, Tao,Wang, Huifeng,Zhang, Rong,Jin, Kun,Wang, Xiuna,Duan, Chunying

supporting information; experimental part, p. 1713 - 1716 (2011/09/12)

A practical and ligand-free Cu-catalyzed decarboxylative trifluoromethylation of aryl iodides with sodium trifluoroacetate using Ag 2O as a promoter was reported. A variety of trifluoromethyl- substituted aromatics are synthesized in moderate to excellent yields and with wide functional-group tolerance under relatively mild reaction conditions. Georg Thieme Verlag Stuttgart · New York.

Silver-mediated trifluoromethylation of arenes using TMSCF3

Ye, Yingda,Lee, Shin Hee,Sanford, Melanie S.

supporting information; experimental part, p. 5464 - 5467 (2011/12/05)

The silver-mediated C-H trifluoromethylation of aromatic substrates using TMSCF3 is described. The development, optimization, and scope of these transformations are reported. AgCF3 intermediates are proposed.

Inhibitors of α4 mediated cell adhesion

-

, (2008/06/13)

The present invention relates to a pharmaceutical composition comprising as an active ingredient a compound of formula (I), wherein Ring A is an aromatic or a heterocyclic ring; Q is a bond, carbonyl, lower alkylene, lower alkenylene, —O-(lower alkylene)-, etc.; n is 0, 1 or 2; Z is oxygen or sulfur, W is oxygen, sulfur, —CH═CH—, —NH— or —N═CH—; R1, R2and R3are the same or different and are hydrogen, halogen, hydroxyl, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted lower alkoxy group, a substituted or unsubstituted amino group, etc.; R4is tetrazolyl, carboxyl group, amide or ester; R5is hydrogen, nitro, amino, hydroxyl, lower alkanoyl, lower alkyl etc.; R6is selected from (a) a substituted or unsubstituted phenyl group, (b) a substituted or unsubstituted pyridyl group, (c) a substituted or unsubstituted thienyl group, (d) a substituted or unsubstituted benzofuranyl group, etc.; or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 158152-56-8